منابع مشابه
To patent or not to patent: the European Union's new biotech directive.
IV. PATENTABILITY OF BIOTECHNOLOGICAL INVENTIONS IN EUROPE............................................................................ 583 A. The European Patent Convention............................. 583 B. Directive 98/44/EC of the European Parliament and the Council of the European Union on the Legal Protection of Biotechnological Inventions ...... 589 1. Procedure for Adoption of a Directi...
متن کاملMisplaced Fears in the Legislative Battle over Affordable Biotech Drugs
Much like tort reform, the debate over recently enacted legislation on biotech drugs—and particularly regulatory supplements to patent protection— has taken on a significance that dwarfs its impact on prescription drug expenditures. Under the Health Care Reform legislation, Congress enacted two major reforms: First, creation of an abbreviated Food and Drug Administration (FDA) approval process ...
متن کاملRuling out and ruling in neural codes.
The subject of neural coding has generated much debate. A key issue is whether the nervous system uses coarse or fine coding. Each has different strengths and weaknesses and, therefore, different implications for how the brain computes. For example, the strength of coarse coding is that it is robust to fluctuations in spike arrival times; downstream neurons do not have to keep track of the deta...
متن کاملMachine Ruling
Emerging technologies, such as big data, Internet of things, cloud computing, mobile Internet, and robotics, breed and expedite new applications and fields. In the mean while, the long-term prosperity and happiness of human race demands advanced technologies. In this paper, the aforementioned emerging technologies are applied to management and governance for the long-term prosperity and happine...
متن کاملQuestionnaire for a Biotech
How and when did your company start, and where are you located? NovaDigm was founded in 2005 by a group of investigators at the los Angeles Biomedical research institute (lA BioMed) and the Division of infectious Diseases at Harbor-UclA Medical center. The company received its first venture capital funding from Domain Associates in 2008 and established its corporate headquarters and laboratory ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 2014
ISSN: 0028-0836,1476-4687
DOI: 10.1038/511138a